focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,485.00
Bid: 3,455.00
Ask: 3,465.00
Change: 20.00 (0.58%)
Spread: 10.00 (0.289%)
Open: 3,475.00
High: 3,490.00
Low: 3,445.00
Prev. Close: 3,465.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited net asset value and portfolio update

7 Oct 2022 07:00

RNS Number : 0819C
Caledonia Investments PLC
07 October 2022
 

Caledonia Investments plc

 

Unaudited net asset value and portfolio update

 

Caledonia Investments plc ("Caledonia") announces that its unaudited diluted net asset value per share ("NAV") as at 30 September 2022, calculated on a cum-income basis, was 5039p. This incorporates the biannual revaluation of the Private Capital portfolio.

 

The NAV total return ("NAVTR") for the six months to 30 September 2022 was 4.5%. A final dividend of 47.3p per ordinary share for the year ended 31 March 2022 plus a special dividend of 175p per ordinary share was paid to shareholders on 4 August 2022, amounting to a payment of £121m.

 

This announcement provides a further update on Caledonia's portfolio and should be read in conjunction with the factsheet dated 30 September 2022 and released on 7 October 2022, a copy of which is available at www.caledonia.com.

 

Summary

 

The underlying performance of our private assets during the first half of the year, in both Private Capital and Funds, coupled with the significant positive impact of the 15% fall in the value of Sterling against the US dollar, has more than offset the volatility and weakness in global equity markets.

 

The Quoted Equity portfolio produced a return of -9.5%, reflecting the broader trend in public equity markets, mitigated to some degree by favourable exchange rate movements. The Private Capital portfolio produced a return of 6.3% following the biannual revaluation of our holdings, with the majority of our investee businesses performing well. The Funds portfolio, which continues to generate cash, returned 22.3% based on the favourable exchange rate position plus valuation growth for our US funds.

 

Performance for the first half is summarised in the table below.

 

Caledonia pool performance

Net asset value - Half Year to 30 September 2022

 

£m

 

 

NAV

31/3/22

Net

investment

/(disposal)

Capital

gains /

(losses)

Other

NAV

30/9/22

Income

Total

Return

Quoted Equity

830.1

4.0

(90.1)

-

744.0

11.4

-9.5%

Private Capital

781.7

(1.3)

36.6

1.9

818.9

12.2

6.3%

Funds

794.4

(16.0)

174.5

-

952.9

1.8

22.3%

Portfolio

2,406.2

(13.3)

121.0

1.9

2,515.8

25.4

Net Cash/(debt)

Other assets

341.1

35.4

13.3

-

-

-

(115.8)

(8.4)

238.6

27.0

Net assets

2,782.7

 

-

121.0

(122.3)

 

2,781.4

NAVTR

4.5%

 

Caledonia has continued to invest and dispose of assets, in line with our active approach to portfolio management. There was a net cash outflow of £103m in the first half of the year, largely reflecting final and special dividends of £121m paid out to shareholders in August. The Quoted Equity pool increased its holdings in three companies, refined positions in a number of others and completed the sale of our holdings in A G Barr and Imperial Brands, creating a net investment outflow of £4m. There was no material transaction activity in the Private Capital portfolio in the period. The Funds portfolio benefitted from a sustained level of fund distributions, resulting in a net cash inflow of £16m in the period.

 

Total liquidity remains healthy with cash of £239m plus undrawn bank facilities of £250m as at 30 September 2022. Caledonia's £250m banking facilities include £137.5m expiring in May 2025, with the balance of £112.5m expiring in July 2025.

 

Caledonia Quoted Equity - Capital and Income portfolios (27% of NAV)

 

The total return on the Quoted Equity pool was -9.5% over the first half of the year. This performance reflected the volatile and challenging nature of the global public equity markets over the last six months. The impact of the notable rise in inflation and resulting interest rate increases, together with the uncertainty created by the conflict in Ukraine, has contributed to weakening market pricing across many sectors. Our portfolios have been directly impacted with most stocks registering price reductions over the period.

 

The Capital portfolio delivered a return of -9.9%. Microsoft, Oracle, Charter Communications and Hill & Smith have seen material price declines, although general underlying trading for these businesses remains strong. With 75% of the portfolio invested in US stocks, the decline in overall return for the period was significantly mitigated by the strength of the US dollar compared to Sterling.

 

The Income portfolio delivered a return of -8.5% with notable valuation falls for our property stocks, Big Yellow Group and London Metric, and for Sabre Insurance. These adverse returns were partially offset by stronger performance by tobacco and consumer products holdings. Our US stocks, representing around 25% of the portfolio, delivered a neutral return with any price declines offset by the movement in exchange rates.

 

Trading activity has been relatively limited, in line with our long-term investment approach. The main activity was to increase our holdings in Moody's, Charter Communications and London Metric. We disposed of our remaining holdings in A G Barr and Imperial Brands. Other activity was restricted to refining positions in existing investments.

 

Caledonia Private Capital (29% of NAV)

 

Caledonia's Private Capital portfolio is dominated by significant positions in four UK centric businesses and one private European investment company. These five investments represent over 90% of the portfolio value. Investee companies are revalued in March and September each year. The portfolio generated a total return of 6.3% in the first half of the year.

 

Seven Investment Management ("7IM"), a vertically integrated multi-asset class investment manager, continues to perform well. Whilst the volatility in public markets has impacted overall assets under management ("AUM"), net investment flows and revenue, the business has continued to grow earnings through the period aided by direct cost savings, higher interest income and a strong performance from recently acquired Partners Wealth Management. AUM was over £20bn at the end of August 2022, down from £21bn at the start of the calendar year, reflecting a mix of negative market movement and positive net fund inflows. Valuation at end September was £184.5m, a return of 8.0% for the first half of the year.

 

Cobepa, the Belgian based investment company, owns a diverse portfolio of private global investments. The businesses within the Cobepa portfolio continue to develop well, with many delivering strong performance and valuation progression. Recent disposals of significant individual assets, most notably Hillebrand and BioAgilytix, have boosted returns and provided liquidity to support new investment opportunities. These factors are reflected in the valuation of Cobehold (the holding company of Cobepa); the valuation of Caledonia's holding at end September was £174.2m, a return of 11.1% for the first half of its year.

 

Stonehage Fleming, the international multi-family office, continues to deliver good earnings growth. The integration of the Maitland private client business, acquired on 31 January 2022, is progressing well. The Family Office division has been delivering good results on the back of new client wins. In contrast, the Investment Management division has been somewhat adversely impacted by the volatility in global public equity markets. Valuation at end September was £141.2m, a return of 3.7% for the first half of the year.

 

Cooke Optics, a leading manufacturer of cinematography lenses, has traded well in recent months following the successful launch of a series of new lenses and delivered strong earnings growth in its most recent financial year to 30 June 2022. The market is strong as global demand for both streaming and cinema content remains elevated. The business has invested in capacity to fulfil this demand and is developing plans to bring several innovative new products to the market. Valuation at end September was £137.1m, an equity return of 22.0% for the first half of the year.

 

Liberation Group, a pub, restaurant and drinks business with operations in the Channel Islands and the South West of the UK, has traded well through the spring and summer. Its portfolio is well positioned with a focus on destination pubs, a strong food offering, large outdoor spaces and, in some cases, quality accommodation. The business has been delivering strong earnings growth as it emerged from the Covid-19 period but is now facing the headwinds of weaker consumer confidence, as cost of living issues dominate the news, and cost pressures, particularly from energy contracts. In mitigation, the cost base is well managed and there remains further upside from the Wadworth estate pubs acquired in December 2020 and other site acquisitions. Valuation at end September was £124.4m, a return of -8.3% for the first half of the year.

 

Caledonia Funds (34% of NAV)

 

Caledonia's Funds investments are principally in third party managed private equity funds operating in North America and in Asia. The total return on the Funds portfolio was 22.3% for the first half of the year. This reflects ongoing valuation growth across the maturing portfolio of US and Asia based funds, plus a significant positive exchange impact given that the majority of these holdings are US dollar denominated. A number of our general partners, particularly Boyne, KLH, CenterOak and New Heritage, produced very strong gains for the period alongside our US fund of funds manager, Aberdeen US private equity funds. 100% of funds, by value, are valued as at 30 June 2022.

 

During the first half of the year, £70m was invested and distributions of £86m were received. The level of distributions remains positive, with notable receipts from specific funds in both the US and Asia, reflecting merger, acquisition and IPO activity in the broader private equity markets.

 

 

Company contacts

Caledonia Investments plc

+44 20 7802 8080

Mathew Masters

Chief Executive Officer

 

Tim Livett

Chief Financial Officer

 

Media contacts

Tulchan Communications

+44 20 7353 4200

Tom Murray

Lisa Jarrett-Kerr

caledonia@tulchangroup.com

 

7 October 2022

 

 

Notes

 

Valuation approach and methodology

 

The valuation approach utilised for each asset portfolio is summarised below.

 

Caledonia Quoted Equity: all listed companies are valued based on the closing bid price on the relevant exchange as at 30 September 2022.

 

Caledonia Private Capital: the holdings are valued biannually, principally on a normalised EBITDA x market multiple basis (in line with the latest IPEV guidelines). This approach was applied to the majority of significant assets in the portfolio on 30 September 2022. There was one exception to this approach; our holding in Cobehold, where fair value was derived from the external valuation prepared by Cobepa.

 

Caledonia Funds: the fund valuations are based on the most recent valuations provided by the fund managers, subject to cash movements from the valuation date. Valuations are received 60 to 180 days from the valuation date.

 

Caledonia Investments plc

 

Caledonia is a self-managed investment trust company. Its aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. This is achieved by investing in proven, well-managed businesses that combine long term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, a range of sectors and, particularly through the listed and fund investments, have a global reach.

 

For additional information on Caledonia, please visit www.caledonia.com.

 

END

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBRBDGSGGDGDL
Date   Source Headline
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.